Short interest for National Beverage gives investors a sense of the degree to which investors are betting on the decline of National Beverage's stock. Short interest data is updated every two weeks.

National Beverage Stock (NASDAQ:FIZZ), Short Interest Report

National Beverage

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.

News

Intraday Update

Markets

Movers

Trading Ideas

FIZZ

LUNR

MYPS

NEWP

OPRA

RSKD

SSYS

SWBI

TOVX

U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Friday. Here are some big stocks recording gains in today’s session.

Stratasys, PLAYSTUDIOS, PlayAGS And Other Big Stocks Moving Higher On Friday

Penny Stocks

Small Cap

ACER

ACLX

AMAM

ARMP

AUTL

AVGO

BIVI

BJDX

BXRX

CJJD

CLRO

CURV

DAKT

DOCU

DOMO

ENSC

ERAS

FLGC

GROM

HARP

HUYA

ICLK

IKNA

JOUT

LULU

MMAT

MOMO

MRIN

MYSZ

NRBO

PBTS

PHVS

PRTY

RENT

RKLY

RNAZ

SBIG

SHF Holdings, Inc. - Class A Common Stock

SHFS

SVFD

SXTC

TIVC

WAVD

WBEV

ZEST

GETR

Gainers


	Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.


Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday&#39;s Mid-Day Session

Earnings

General

National Beverage Registers 5.8% Revenue Growth In Q2

National Beverage Corp

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported quarterly earnings of $0.420 per share which beat the analyst consensus estimate of $0.410 by 2.44 percent. The company reported quarterly sales of $270.000 million which missed the analyst consensus estimate of $273.830 million by 1.40 percent. This is a 0.57 percent increase over sales of $268.483 million the same period last year.

Earnings Beats

Earnings Misses

National Beverage Q3 2024 GAAP EPS $0.420 Beats $0.410 Estimate, Sales $270.000M Miss $273.830M Estimate

National Beverage Corp Q2 2024 EPS $0.47 Up From $0.39 YoY, Revenue $300.1M Misses $305.630 Estimate

Cecil D Conlee, Board Member at National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>), reported a large insider sell on October 18, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000069891/000143774923028520//Archives/edgar/data/69891/000143774923028520/0001437749-23-028520-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that Conlee sold 13,200 shares of National Beverage. The total transaction amounted to $601,150. 
National Beverage shares are trading down 0.0% at $45.14 at the time of this writing on Thursday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000069891">Check Out The Full List Of National Beverage's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Board Member of National Beverage Makes $601K Sale

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported quarterly earnings of $0.53 per share which met the analyst consensus estimate. This is a 39.47 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $324.00 million which missed the analyst consensus estimate of $327.66 million by 1.12 percent. This is a 1.85 percent increase over sales of $318.12 million the same period last year.

National Beverage Q1 EPS $0.53, Inline, Sales $324.00M Miss $327.66M Estimate

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro,</a> during Q4, National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) earned $36.30 million, a 5.65% increase from the preceding quarter. National Beverage also posted a total of $286.70 million in sales, a 6.78% increase since Q3. In Q3, National Beverage earned $34.36 million, and total sales reached $268.48 million. 
<h3>What Is Return On Capital Employed?</h3>
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q4, National Beverage posted an ROCE of 0.1%.
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future. 
ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows National Beverage is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth. 
For National Beverage, the positive return on capital employed ratio of 0.1% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
<h3>Upcoming Earnings Estimate</h3>
National Beverage reported Q4 earnings per share at $0.39/share, which did not meet analyst predictions of $0.39/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Looking Into National Beverage's Return On Capital Employed

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported its Q4 earnings results on Wednesday, June 28, 2023 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
National Beverage reported in-line EPS of $0.39 versus an estimate of $0.39.
Revenue was up $2.48 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.05 which was followed by a 2.27% increase in the share price the next day.

 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for National Beverage <a href="https://www.benzinga.com/quote/FIZZ/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: National Beverage Q4 Earnings

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported quarterly earnings of $0.39 per share which met the analyst consensus estimate. This is a 8.33 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $287.00 million which missed the analyst consensus estimate of $296.98 million by 3.36 percent. This is a 0.98 percent increase over sales of $284.22 million the same period last year.

National Beverage Q4 EPS $0.39, Inline, Sales $287.00M Miss $296.98M Estimate

<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data,</a> National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) posted Q3 earnings of $34.36 million, an increase from Q2 of 4.67%. Sales dropped to $268.48 million, a 10.4% decrease between quarters. In Q2, National Beverage earned $36.05 million, and total sales reached $299.63 million. 
<h3>What Is Return On Capital Employed?</h3>
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q3, National Beverage posted an ROCE of 0.1%.
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future. 
ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows National Beverage is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth. 
For National Beverage, the positive return on capital employed ratio of 0.1% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
<h3>Upcoming Earnings Estimate</h3>
National Beverage reported Q3 earnings per share at $0.37/share, which beat analyst predictions of $0.32/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

National Beverage's Return On Capital Employed Insights

U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Friday. Here are some big stocks recording gains in today&rsquo;s session.
<ul>
<li>PLAYSTUDIOS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myps#NASDAQ">MYPS</a>) jumped 20.5% to $4.1814 after reporting upbeat quarterly results.</li>
<li>PlayAGS, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ags#NYSE">AGS</a>) shares rose 18.3% to $7.51 after the company posted better-than-expected Q4 results.</li>
<li>Riskified Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rskd#NYSE">RSKD</a>) surged 14.7% to $6.17. Piper Sandler upgraded Riskified from Neutral to Overweight and raised the price target from $6 to $8.</li>
<li>Intuitive Machines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lunr#NASDAQ">LUNR</a>) climbed 12.4% to $18.21 after gaining around 58% on Thursday.</li>
<li>Opera Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opra#NASDAQ">OPRA</a>) jumped 11.3% to $9.53. Opera recently reported better-than-expected Q4 financial results.</li>
<li>Theriva Biologics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tovx#NYSE">TOVX</a>) gained 11% to $0.82.</li>
<li>HCI Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hci#NYSE">HCI</a>) rose 10.7% to $58.33 after reporting a profit for the fourth quarter.</li>
<li>Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) gained 10.2% to $15.44 after Nano Dimension announced a formal offer to acquire the company for $18 per share.</li>
<li>Smith &amp; Wesson Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swbi#NASDAQ">SWBI</a>) rose 9.5% to $11.38 following strong Q3 results.</li>
<li>DRDGOLD Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/drd#NYSE">DRD</a>) gained 9% to $7.38.</li>
<li>New Pacific Metals Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newp#NYSE">NEWP</a>) rose 7.6% to $2.3999.</li>
<li>National Beverage Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fizz#NASDAQ">FIZZ</a>) gained 7.2% to $49.65 following upbeat quarterly results.</li>
<li>Target Hospitality Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/th#NASDAQ">TH</a>) rose 6.5% to $16.78 following Q4 results.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/23/03/31296559/bitcoin-tumbles-below-this-key-level-conflux-huobi-token-among-top-losers"> Bitcoin Tumbles Below This Key Level; Conflux, Huobi Token Among Top Losers</a>

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.32 by 15.62 percent. This is a 12.12 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $268.48 million which beat the analyst consensus estimate of $263.46 million by 1.91 percent. This is a 3.69 percent increase over sales of $258.92 million the same period last year.

National Beverage Q3 EPS $0.37 Beats $0.32 Estimate, Sales $268.48M Beat $263.46M Estimate

Upgrades

Downgrades

Initiation

Analyst Ratings

ADSE

AMPL

AMPS

AMWL

AMZN

APEN

ARBK

BHVN

BIGC

BURL

CHRW

CLFD

CYBR

DCPH

ENFN

ENTG

ETSY

EZPW

FROG

FRSH

FWRD

GOOGL

GTLS

HAYW

HUBB

ICVX

INVH

IRON

JBHT

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MSFT

MTCH

NFLX

NTRS

OKTA

OSTK

PSTX

PWSC

RAPT

ROIC

SCHW

SEER

SNAP

SPRY

VEEV

VERA

Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023

Jefferies analyst Kevin Grundy downgrades National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) from Hold to Underperform and lowers the price target from $42 to $38.

Price Target

Jefferies Downgrades National Beverage to Underperform, Lowers Price Target to $38

<h3>Gainers</h3>
<ul>
<li>Ambrx Biopharma Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amam#NYSE">AMAM</a>) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.</li>
<li>ClearOne, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clro#NASDAQ">CLRO</a>) gained 85% to $1.51 after the company and Shure Incorporated announced they reached a global settlement of all pending legal disputes.</li>
<li>Rockley Photonics Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rkly#NYSE">RKLY</a>) rose 48.3% to $0.4218 after jumping 18% on Thursday. Rockley Photonics, last month, reported worse-than-expected Q3 sales results and issued 2022 revenue guidance below estimates.</li>
<li>Marin Software Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrin#NASDAQ">MRIN</a>) shares climbed 34.5% to $1.52. Marin Software joined the Walmart Platform Partner program as an API partner.</li>
<li>UpHealth, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uph#NYSE">UPH</a>) shares climbed 30.6% to $3.06. Healthcare transformation expert Timothy Wilde joined UpHealth as Chief Technology Officer.</li>
<li>China Jo-Jo Drugstores, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjjd#NASDAQ">CJJD</a>) gained 29.4% to $2.7953.</li>
<li>Hello Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/momo#NASDAQ">MOMO</a>) jumped 29% to $8.77. Morgan Stanley upgraded Hello Group from Equal-Weight to Overweight and raised the price target from $5 to $9.</li>
<li>Arcellx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aclx#NASDAQ">ACLX</a>) gained 27.8% to $27.71. Kite, a Gilead Sciences Inc company, announced a global strategic collaboration to co-develop and co-commercialize Arcellx&rsquo;s lead late-stage product candidate, CART-ddBCMA, for relapsed or refractory multiple myeloma. Arcellx also announced interim CART-ddBCMA Phase 1 results (October 31, 2022 cutoff date), demonstrating deep and durable responses.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) shares gained 23% to $5.01 after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.</li>
<li>Daktronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dakt#NASDAQ">DAKT</a>) jumped 23% to $2.1518. Daktronics delayed its earnings release to address the determination that there is &#39;substantial doubt&#39; over its ability to continue as a going concern.</li>
<li>Acer Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acer#NASDAQ">ACER</a>) gained 21% to $1.90. Acer Therapeutics recently reported a $1.5 million private placement.</li>
<li>HUYA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/huya#NYSE">HUYA</a>) rose 20.6% to $3.39.</li>
<li>NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) shares rose 20.4% to $2.0907 after gaining 25% on Thursday. Ladenburg Thalmann recently initiated coverage on NeuroBo Pharmaceuticals with a Buy rating and announced a price target of $6.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) gained 19.2% to $1.1799.</li>
<li>SpringBig Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbig#NASDAQ">SBIG</a>) jumped 18.4% to $0.7578.</li>
<li>Powerbridge Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbts#NASDAQ">PBTS</a>) rose 18.3% to $0.1341. Powerbridge Technologies, last month, announced the strategic acquisition of DTI Group.</li>
<li>Domo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) gained 17.7% to $17.53 following better-than-expected Q3 results.</li>
<li>Armata Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/armp#NYSE">ARMP</a>) jumped 17.7% to $2.26.</li>
<li>Phreesia, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phr#NYSE">PHR</a>) rose 16.4% to $31.08 after the company posted upbeat Q3 sales and raised FY23 revenue guidance.</li>
<li>Braemar Hotels &amp; Resorts Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhr#NYSE">BHR</a>) gained 16.2% to $4.01. Braemar Hotels &amp; Resorts announced an increase in quarterly dividend from $0.01 per share to $0.05 per share and authorized $25 million for share repurchases.</li>
<li>DocuSign, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/docu#NASDAQ">DOCU</a>) rose 15.8% to $50.68 after the company reported better-than-expected financial results for its third quarter and issued strong guidance. Piper Sandler upgraded the stock from Underweight to Neutral and lowered the price target from $54 to $50.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iclk#NASDAQ">ICLK</a>) gained 14.9% to $4.0901.</li>
<li>Johnson Outdoors Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jout#NASDAQ">JOUT</a>) jumped 12.8% to $64.83 following better-than-expected quarterly results.</li>
<li>Ikena Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikna#NASDAQ">IKNA</a>) gained 12.7% to $3.09.</li>
<li>Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) jumped 11.8% to $1.07.</li>
<li>Ecoark Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zest#NASDAQ">ZEST</a>) gained 9.3% to $0.59.</li>
<li>WaveDancer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wavd#NASDAQ">WAVD</a>) jumped 9.3% to $0.66.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) rose 8.9% to $8.07.</li>
<li>National Beverage Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fizz#NASDAQ">FIZZ</a>) gained 8% to $52.33 following Q2 results.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) rose 8% to $0.5199 after dropping 13% on Thursday.</li>
<li>Broadcom Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgo#NASDAQ">AVGO</a>) gained 3.7% to $550.93 as the company reported better-than-expected results for its fourth quarter and issued strong sales forecast for the current quarter. Broadcom also raised the quarterly dividend by 12% to $4.60 per share.</li>
</ul>
&nbsp;
<h3>Losers</h3>
<ul>
<li>Getaround Inc. (NYSE: GETR) shares tumbled 64.8% to $3.10. Getaround reported closing of business combination with InterPrivate II Acquisition Corp.</li>
<li>Grom Social Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grom#NASDAQ">GROM</a>) dipped 58% to $1.6195. Grom Social Enterprises priced $5 million public offering of 1,415,682 units at a price of $2.89 per unit</li>
<li>Autolus Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/autl#NASDAQ">AUTL</a>) fell 34.9% to $1.9475 after the company announced pricing of a public offering. The company&rsquo;s Phase 2 pivotal FELIX trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukemia (ALL) has met its primary endpoint of Overall Remission Rate (ORR).</li>
<li>Meta Materials Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmat#NASDAQ">MMAT</a>) dropped 24.6% to $1.3799. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META&#39;s Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.</li>
<li>My Size, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mysz#NASDAQ">MYSZ</a>) fell 24% to $3.61.</li>
<li>Winc, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wbev#NYSE">WBEV</a>) dropped 19% to $0.17.</li>
<li>Erasca, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eras#NASDAQ">ERAS</a>) fell 17.6% to $6.03 after the company priced a 15,384,616 share offering at $6.50 per share.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) dropped 16.9% to $7.56.</li>
<li>Flora Growth Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgc#NASDAQ">FLGC</a>) fell 16.8% to $0.37 after the company announced pricing of a $5 million registered direct offering.</li>
<li>Sunlands Technology Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stg#NYSE">STG</a>) declined 16.4% to $6.18.</li>
<li>Rent the Runway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) fell 15% to $2.0150. Rent The Runway shares jumped 74% on Thursday after the company reported better-than-expected Q3 sales results.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bjdx#NASDAQ">BJDX</a>) declined 15% to $0.45.</li>
<li>Save Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svfd#NASDAQ">SVFD</a>) dipped 14.3% to $0.8999.</li>
<li>Pharvaris N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phvs#NASDAQ">PHVS</a>) shares fell 14.2% to $9.83. Pharvaris shares jumped 339% on Thursday after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks.</li>
<li>SHF Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shfs#NASDAQ">SHFS</a>) dropped 13.6% to $3.4995.</li>
<li>Sono Group N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sev#NASDAQ">SEV</a>) fell 13.2% to $0.9632. Sono Group shares dropped 5% on Thursday after the company reported worse-than-expected Q3 EPS results.</li>
<li>Torrid Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/curv#NYSE">CURV</a>) declined 13.1% to $3.7099 after the company reported worse-than-expected Q3 EPS and sales results and issued Q4 2022 and FY22 revenue guidance below estimates.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) dropped 12.3% to $0.9550. Tivic Health and Reliefband Technologies, LLC terminated acquisition agreement.</li>
<li>Lululemon Athletica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>) fell 12.3% to $328.35. Lululemon posted upbeat results for its third quarter, but issued weak holiday-quarter guidance.</li>
<li>Party City Holdco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/prty#NYSE">PRTY</a>) fell 12.1% to $0.5210.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) shares fell 11.3% to $0.6441after declining over 25% on Thursday. TransCode Therapeutics recently announced withdrawal of the Registration Statement on Form S-1 filed on November 28, 2022 for a share offering for up to 12.5 million.</li>
</ul>
Also check this out <a href="https://www.benzinga.com/markets/cryptocurrency/22/12/30022592/bitcoin-tops-this-key-level-the-graph-emerges-as-top-gainer"> Bitcoin Tops This Key Level; The Graph Emerges As Top Gainer</a>

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session

<ul>
<li>National Beverage Corp&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fizz#NASDAQ">FIZZ</a>) reported&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/22/12/b30014986/national-beverage-corp-reports-highest-second-quarter-sales" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">second-quarter FY22 sales growth of 5.8%</a>&nbsp;to $299.63 million.</li>
<li>Gross profit fell 1.5% to $99.99 million, while the margin contracted 240 basis points to 33.4%.</li>
<li>The operating margin was 15.7%, and operating income for the quarter was $46.9 million.</li>
<li>National Beverage&nbsp;held $92.6 million in cash and equivalents as of October 29, 2022.</li>
<li>EPS for the quarter was $0.39 versus $0.42 last year.</li>
<li>Price Action:&nbsp;FIZZ shares are trading higher by 5.86% at $51.72 on the last check Friday.</li>
</ul>

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported quarterly earnings of $0.39 per share. This is a 7.14 percent decrease over earnings of $0.42 per share from the same period last year. The company reported $299.63 million in sales this quarter. This is a 5.82 percent increase over sales of $283.16 million the same period last year.

National Beverage Q2 EPS $0.39 Down From $0.42 YoY, Sales $299.63M Up From $283.16M YoY

WIIM

MNST

Shares of beverage companies are trading lower amid overall market weakness. Concerns of future Fed rate hikes following Tuesday's CPI reading have caused feared of an economic slowdown, which could weigh on consumer spending.

UBS analyst Peter Grom maintains National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) with a Sell and lowers the price target from $43 to $42.

UBS Maintains Sell on National Beverage, Lowers Price Target to $42

National Beverage shares are trading lower after the company reported Q1 EPS results down from last year.

National Beverage Q1 EPS $0.38 Down From $0.58 YoY, Sales $318.10M Up From $311.70M YoY

US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company&rsquo;s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/i3nsider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Patterson-UTI Energy </h2>
<ul>
<li>The Trade: Patterson-UTI Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pten#NASDAQ">PTEN</a>) President and CEO Andrew William Hendricks Jr <a href="https://www.benzinga.com/sec/insider-trades/"> sold a total of 100,000 shares </a> at an average price of $13.76. The insider received around $1.38 million from selling those shares.</li>
<li>What&rsquo;s Happening: Morgan Stanley recently maintained Patterson-UTI Energy with an Overweight and lowered the price target from $20 to $18.</li>
<li>What Patterson-UTI Energy Does: Patterson-UTI Energy is one of the largest land rig drilling contractors in the United States and maintains moderately sized pressure-pumping operations primarily in Texas and the Appalachian region.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/07/28063759/markets-in-extreme-fear-with-rising-inflation-rates">Also check this: Markets In Extreme Fear With Rising Inflation Rates </a>
<h2>Box </h2>
<ul>
<li>The Trade: Box, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/box#NYSE">BOX</a>) CFO Dylan Smith <a href="https://www.benzinga.com/sec/insider-trades/"> sold a total of 13,000 shares </a> at an average price of $26.45. The insider received around $343.81 thousand as a result of the transaction.</li>
<li>What&rsquo;s Happening: Box reported better-than-expected Q1 sales and issued Q2 sales guidance above estimates in May.</li>
<li>What Box Does: Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers.</li>
</ul>
Have a look at our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h2>National Beverage </h2>
<ul>
<li>The Trade: National Beverage Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fizz#NASDAQ">FIZZ</a>) Director Cecil D Conlee <a href="https://www.benzinga.com/sec/insider-trades/"> sold a total of 12,000 shares </a> at an average price of $49.52. The insider received around $594.24 thousand from selling those shares.</li>
<li>What&rsquo;s Happening: National Beverage reported a decline in FY22 earnings.</li>
<li>What National Beverage Does: National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S.</li>
</ul>

PTEN

National Beverage And 2 Other Stocks Insiders Are Selling

The 52 rating InvestorsObserver gives to National Beverage Corp. (FIZZ)  stock puts it near the top of the Consumer Defensive sector.In addition to scoring higher than 72 percent of stocks in the Consumer Defensive sector, FIZZ's 52 overall rating means the stock scores better than 52 of all stocks. FIZZ has an Overall Sco

Is National Beverage Corp. (FIZZ) a Winner in the Consumer Defensive Sector?

Celsius, Kraft Heinz and Oatly lead strong day for food and beverage stocks

National Beverage Corp. (FIZZ) is the highest overall rated company in the Beverages - Non-Alcoholic industry with an overall score of 76. FIZZ is up 15.68% so far this year after the company closed yesterday at $51.42.  The overall score measures the company's performance based-off both short and long term indicators and

National Beverage Corp. (FIZZ) Is the Top Stock in the Beverages - Non-Alcoholic Industry?

Energizing stuff: Celsius and Monster lead other beverage stocks higher after earnings

National Beverage Corp. (FIZZ) leads the Beverages - Non-Alcoholic industry with an overall score of 74. FIZZ is up 12.99% so far this year after the company closed yesterday at $52.64.  The overall score measures the company's performance based-off both short and long term indicators and means that FIZZ scores better than

Is National Beverage Corp. (FIZZ) Stock Near the Top of the Beverages - Non-Alcoholic Industry?

Earnings week ahead: NIO, Costco, Target, JD.com, CrowdStrike, DocuSign and more

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
National Beverage (NASDAQ:<a href="https://investorplace.com/stock-quotes/fizz-stock-quote/">FIZZ</a>) just reported results for the third quarter of 2024.<ul><li>National Beverage reported earnings per share of 42 cents. This was above the analyst estimate for EPS of 41 cents.</li><li>The company reported revenue of $270.07 million.</li><li>This was 1.37% worse than the analyst estimate for revenue of $273.83 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/fizz-stock-earnings-national-beverage-for-q3-of-2024/">FIZZ Stock Earnings: National Beverage Beats EPS, Misses Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FIZZ Stock Earnings: National Beverage Beats EPS, Misses Revenue for Q3 2024

Earnings week ahead: Oracle, Adobe, Zim Integrated and more

U.S. beverage sales cooled off but energy drinks, tequila and prepared cocktails are still hot

-

-

-

-

-

-

-

-

-

-

-

-

-

-

National Beverage Stock (NASDAQ:FIZZ), Short Interest Report

People Also Watch